Can you believe we are well into February already! Red is the color that seems to rule this month. Did you remember to wear your RED on 2/4 for National Wear Red Day to raise awareness about heart disease in Women? If you forgot, no problem. It is always the first Friday in February.
|
Educational Opportunities for new Healthcare Value Analysis Professionals
Are you new to value analysis? Are you looking for education to help you grow in your role and gain knowledge about the Healthcare Value Analysis process? The AHVAP “Resources” webpage should be your first stop.
Healthcare Value Analysis Academy
This online course was created by experienced Value Analysis professionals to educate participants on the four pillars that comprise the foundation of Healthcare Value Analysis: Governance and Structure, Healthcare Value Analysis Methodology, Professionalism and Business Ethics, and Finance. The course provides valuable information for new VA practitioners, those responsible for managing the process and those who participate in the process: VA professionals, Sourcing managers, VA team members, Infection Prevention Professionals, Supply Chain Leaders, and Supplier Representatives to name a few.
Resource Library
Under this topic, members will find the AHVAP Glossary, samples of value analysis forms and tools used by professional peers, job descriptions, and even PowerPoint Presentations about value analysis.
Podcasts
Tune in to presentations from professional peers who share their knowledge and experience applying the principles of healthcare value analysis to achieve organizational goals for quality, safety, financial stewardship and patient satisfaction. These 30-minute presentations provide valuable professional insights and operational tips.
Opportunity for CVAHP Certification for Seasoned Professionals
Once you have gained the skills and knowledge necessary to apply the healthcare value analysis process, CVAHP Certification is the mark of distinction for healthcare value analysis professionals.
“Certification is defined as an official document attesting to a status or level of achievement. The CVAHP is a validation of knowledge in the area of value analysis. To me certification is a matter of pride, I include it in every introduction. It is valuable to me to demonstrate my expertise as a professional in the industry. Recognition of achievement should not be underestimated both for current roles and responsibilities as for future advancements.”
Dee Donatelli, BSN, CMRP, CVAHP, MBA, RN
Vice President, SYMPLR
All About CVAHP Certification
Under the “Certification” tab, click on “Requirements & FAQs” for everything you need to know to apply for the CVAHP Exam.
Whether you are looking for educational resources or you are ready to be CVAHP certified, take advantage of the opportunities available to you in this New Year.
|
 
|
|
If you could not join us live February 2 at noon EST, tune in to the AHVAP PODCAST Channel and hear firsthand how one IDN progressed through the value analysis maturity phases from 2017 to today and beyond.
Title: “Outcomes Based Savings Program: Success Using Long Term Value Based Strategic Partnerships”
Guest: Kristen Sinke, MSN, RN, CVAHP-Director, Value Analysis Spectrum Health, Grand Rapids, MI.
Click Here to Access the Podcast Channel
|
In support of its strategic goals, AHVAP nurtures relationships with other organizations to bring continued awareness of the importance of value analysis to the delivery of healthcare.
Federation of American Hospitals and AHVAP are collaborating at the 2022 FAH Conference and Business Exposition March 6-8, 2022, at the Washington Hilton in Washington, D.C. Stop by the AHVAP table and get acquainted with our education, certification and networking opportunities. Learn more here.
Later in the Spring, AHVAP is collaborating with Health Connect Partner’s Supply Chain Event in New Orleans, Louisiana, May 18-20, 2022. AHVAP will be participating in the Reverse Expo as well as presenting a panel discussion titled “Clinical Integration Through the Lens of Value Analysis." Terri Nelson, AHVAP Central Region Director, Gloria Graham, AHVAP Northeast Region Director and Laura Polson, AHVAP Past President will provide their insights to topics moderated by Barbara Strain, AHVAP Strategic Board Liaison. Learn more here.
|
|
|
Reuters
COVID-19 border closures in early 2020 choked shipments from Asia, producer of about 80% of the world's medical masks and protective gear, OSF HealthCare and some other hospital groups started investing in U.S. production of key supplies including masks, gowns and critical pharmaceuticals. The goal: Avoid a repeat of the early pandemic's life-threatening shortages of essential protective gear - an effort that has become vitally important as schools, employers, consumers and the federal government are snapping up high-quality N95s and other masks to shield against the highly contagious Omicron variant.
|
Managed Healthcare Executive
The healthcare industry is known for being careful and cautious, so one could be forgiven for assuming that healthcare and cryptocurrency have little in common. While the healthcare industry demands safety and risk-mitigation, cryptocurrency is built on a high-risk, high-reward model in which a tiny investment can turn into a fortune and back again at the speed of an eccentric billionaire’s tweet. Yet the backbone of cryptocurrency — blockchain technology — could soon be a very important part of the healthcare industry.
|
The Washington Post
Nearly all of the money in a key federal program to boost coronavirus testing, therapeutics and vaccines appears to have been committed or already shelled out, raising the potential that the Biden administration may have to ask Congress to approve additional aid. The dwindling funds reflect an uptick in spending as the White House in recent months has labored aggressively to battle back the rise of the omicron variant.
|
Politico
The Health and Human Services Department has failed to fix long-standing problems in its pandemic response, putting its ability to respond to future emergencies in jeopardy, the Government Accountability Office said in a report Thursday. The watchdog agency included HHS on its “High Risk List” of federal departments and programs susceptible to mismanagement and abuse without significant changes, such as drug and medical product oversight. Three dozen agencies and federal programs are currently on the list.
|
|
|
CNN
Sens. Patty Murray and Richard Burr on Tuesday proposed a bipartisan bill that would bolster the US' pandemic preparedness and probe the origins of COVID-19. The PREVENT Pandemics Act would "examine what has worked, and what has not, during the nation's response to the COVID-19 pandemic, and incorporates ideas from multiple members on both sides of the aisle," according to a news release from the Senate Health, Education, Labor and Pension Committee.
|
Newsweek
Anew World Health Organization (WHO) report shared on Tuesday warned that the COVID-19 pandemic has contributed to tens of thousands of tons of medical waste, adding considerable strain on health care systems and the environment. The 71-page document by the U.N. health agency stated that 87,000 tons of personal protective equipment (PPE) were ordered through a U.N. portal between March 2020 and November 2021 and ended up as medical waste.
|
Cornell Chronicle
Under the intensity of a prolonged pandemic, the world finds an ever-growing and seemingly never-ending waste stream of used surgical masks, plastic face shields, and medical gloves and gowns. Cornell engineers now offer a solution to sustainably reroute the discarded material. A medium-temperature reaction called pyrolysis can reduce the plasticized medical-protection garb back into an original form – such as chemicals and petroleum – and then recycle it, perhaps into fuels, according to a new study.
|
The Hill
Johnson & Johnson temporarily halted production of its COVID-19 vaccine in The Netherlands, the only manufacturing hub making usable doses for the pharmaceutical company, according to a New York Times report on Tuesday. The company stopped production of the vaccine at its facility in the Dutch city of Leiden at the end of 2021 and has instead turned its attention to making another vaccine for an unrelated virus, The Times reported.
|
|
.jpg)
